Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Growth hormone deficiency (GHD) is a medical condition characterized by insufficient production of somatropin, a growth hormone, from the anterior pituitary gland which is responsible for the growth and cell reproduction.
The primary factor contributing to the growth of global growth hormone deficiency treatment market is increasing incidence of growth hormone deficiency syndrome. Several other factors which may cause the global growth hormone deficiency market to grow include changing lifestyle, prevalence of other genetic disorders and incidence of GHD in adults.
In the coming years, this disorder can be treated by various therapeutics which are currently in their final phase of development. This would change the complete market scenario because at present only daily agents are used to treat GHD. The global human growth hormone market is likely to see strong pipeline of drugs with increased research and development activities, which would spur innovation in the market.
The global human growth hormone market is expected to experience robust growth post the launch of therapeutic drugs, primarily due to increasing patient base, and long-acting hGH formulations in development. However, the market growth is hindered by high R&D expenditures and expensive drug costs.
In 2018, the global Growth Hormone Deficiency Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Growth Hormone Deficiency Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Growth Hormone Deficiency Treatment development in United States, Europe and China.
The key players covered in this study
Sandoz International
Sanofi Aventis
Pfizer
Novo Nordisk
Teva Pharmaceutical
Ranbaxy
EMD Serono
Sun Pharmaceutical
Eli Lilly
Market segment by Type, the product can be split into
Pharmacological Therapy
Recombinant Human Growth Hormone
Human Pituitary Gland Extracts
Surgery
Market segment by Application, split into
Hospitals
Clinics
Home Care Settings
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Growth Hormone Deficiency Treatment status, future forecast, growth opportunity, key market and key players.
To present the Growth Hormone Deficiency Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Growth Hormone Deficiency Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
The primary factor contributing to the growth of global growth hormone deficiency treatment market is increasing incidence of growth hormone deficiency syndrome. Several other factors which may cause the global growth hormone deficiency market to grow include changing lifestyle, prevalence of other genetic disorders and incidence of GHD in adults.
In the coming years, this disorder can be treated by various therapeutics which are currently in their final phase of development. This would change the complete market scenario because at present only daily agents are used to treat GHD. The global human growth hormone market is likely to see strong pipeline of drugs with increased research and development activities, which would spur innovation in the market.
The global human growth hormone market is expected to experience robust growth post the launch of therapeutic drugs, primarily due to increasing patient base, and long-acting hGH formulations in development. However, the market growth is hindered by high R&D expenditures and expensive drug costs.
In 2018, the global Growth Hormone Deficiency Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Growth Hormone Deficiency Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Growth Hormone Deficiency Treatment development in United States, Europe and China.
The key players covered in this study
Sandoz International
Sanofi Aventis
Pfizer
Novo Nordisk
Teva Pharmaceutical
Ranbaxy
EMD Serono
Sun Pharmaceutical
Eli Lilly
Market segment by Type, the product can be split into
Pharmacological Therapy
Recombinant Human Growth Hormone
Human Pituitary Gland Extracts
Surgery
Market segment by Application, split into
Hospitals
Clinics
Home Care Settings
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Growth Hormone Deficiency Treatment status, future forecast, growth opportunity, key market and key players.
To present the Growth Hormone Deficiency Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Growth Hormone Deficiency Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
